A comparative study to assess the efficacy of Ayurvedic formulation and Cognitive Behavioural Therapy in managing Generalized Anxiety Disorder
Phase 3
Not yet recruiting
- Conditions
- Health Condition 1: F411- Generalized anxiety disorder
- Registration Number
- CTRI/2024/07/070878
- Lead Sponsor
- Vaidyaratnam Ayurveda college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Clinically diagnosed cases of Generalized Anxiety Disorder based on ICD10 Criteria
2.20- 50 age group irrespective of gender, caste, religion and economic status.
3.Diagnosis should be confirmed by a specialist in Manasikaroga Vijnana
Exclusion Criteria
•Patients with psychiatric disorder & other systemic and metabolic disorders
•Drug abuse and withdrawal patient.
•Pregnant women, Lactating women.
•Participants having completed any other trial within 6 months.
•Patients taking allopathic medications for GAD
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Saraswatham Choornam's anxiolytic effects in Generalized Anxiety Disorder?
How does Ayurvedic formulation compare to SSRIs in managing GAD symptoms when combined with CBT?
Are there specific biomarkers that predict response to Saraswatham Choornam in F411 GAD patients?
What adverse events are associated with Saraswatham Choornam as an add-on to CBT in GAD treatment?
What combination therapies are being explored for Generalized Anxiety Disorder alongside Ayurvedic interventions?